Health Care & Life Sciences » Healthcare Provision | Fleury S/A

Fleury S/A Ord | Income Statement

Fiscal year is January-December. All values BRL Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,657
1,679
1,895
2,096
2,383
2,664
Cost of Goods Sold (COGS) incl. D&A
1,311
1,304
1,423
1,528
1,690
1,906
Gross Income
346
375
472
568
693
758
SG&A Expense
191
185
193
215
214
245
EBIT
170
199
-
347
481
506
Unusual Expense
-
-
7
-
1
-
Non Operating Income/Expense
11
4
36
18
13
28
Interest Expense
87
116
137
136
85
84
Pretax Income
111
144
172
293
427
450
Income Tax
50
58
65
66
107
120
Equity in Affiliates
-
-
-
1
1
1
Consolidated Net Income
61
86
107
229
321
332
Net Income
61
86
107
229
321
332
Net Income After Extraordinaries
61
86
107
229
321
332
Net Income Available to Common
61
86
107
229
321
332
EPS (Basic)
0.20
0.28
0.35
0.73
1.02
1.05
Basic Shares Outstanding
313
313
313
313
315
315
EPS (Diluted)
0.20
0.27
0.34
0.72
0.99
1.03
Diluted Shares Outstanding
313
313
316
319
325
323
EBITDA
279
313
394
492
624
696
Other Operating Expense
15
9
7
6
1
7
Non-Operating Interest Income
46
57
73
101
45
-

About Fleury

View Profile
Address
Avenida General Valdomiro de Lima
São Paulo Sao Paulo 04344
Brazil
Employees -
Website http://www.fleury.com.br
Updated 07/08/2019
Fleury SA engages in the provision of medical diagnostic services. Its brands include Fleury, Weinmann, Clínica, Felippe Mattoso a+, Labs a+, Diagnoson a+, and Serdil. The company operates through the following business segments: Diagnostic Medicine, Integrated Medicine, and Dental.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.